ABIOMED, Inc. - Medical Equipment - Deals and Alliances Profile

ABIOMED, Inc. - Medical Equipment - Deals and Alliances Profile

Summary

Global Market Direct’s ABIOMED, Inc. - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

ABIOMED, Inc. (Abiomed) is a global technology company, engaged in providing medical devices in circulatory support that offer a continuum of care in heart recovery of acute heart failure patients. The company’s products are designed to improve blood flow and to perform the pumping function of the heart to permit the heart to rest, heal and recover. Abiomed operates in the US, Europe, Australia, China, Italy, Japan, Latin America and Middle East. The company is headquartered in Massachusetts, the US.

And More inside the report…

Recent Developments

Dec 17, 2009: Abiomed Presents European Study Results For Impella 2.5
Nov 05, 2009: Abiomed Reports Total Revenues Of $20.02 Million In Q3 2009
Aug 06, 2009: Abiomed Reports Revenues Of $19.9 Million In Q1 Fiscal 2010

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including mergers & acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick “one-stop-shop” to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.

Report Highlights

The following companies are the major competitors of ABIOMED, Inc.:

Thoratec Corporation
SynCardia Systems, Inc.
World Heart Corporation
Ventracor Limited
Berlin Heart GmbH
Jarvik Heart, Inc.
[Studien Infos ausblenden]

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
ABIOMED, Inc., Medical Equipment, Deals By Year, 2004 to YTD 2010 4
ABIOMED, Inc., Medical Equipment Deals By Type, 2004 to YTD 2010 5
ABIOMED, Inc., Medical Equipment, Deals By Region, 2004 to YTD 2010 6
ABIOMED, Inc., Medical Equipment, Deals By Market, 2004 to YTD 2010 7
ABIOMED, Inc., Medical Equipment, Deals Summary, 2004 to YTD 2010 8
ABIOMED, Inc., Medical Equipment, Deal Details 9
Partnerships 9
ABIOMED Enters Into An Agreement With Opsens 9
Equity Offering 10
ABIOMED Completes Public Offering Of $42.06 Million 10
ABIOMED Completes Public Offering Of $69.85 Million 11
Acquisition 12
ABIOMED Acquires Impella Cardiosystems 12
Key Competitors 13
Key Employees 13
Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Recent Developments 15
Strategy And Business Planning 15
Jul 30, 2008: Abiomed To Operate Manufacturing Facility In Ireland 15
Dec 31, 2007: Abiomed Announces Expansion In European Markets 15
Dec 19, 2007: WorldHeart Enters Strategic Alliance With Abiomed 15
Financial Announcements 15
Jan 07, 2010: Abiomed Reports Preliminary Q3 Fiscal 2010 Results 15
Nov 05, 2009: Abiomed Reports Total Revenues Of $20.02 Million In Q3 2009 16
Aug 06, 2009: Abiomed Reports Revenues Of $19.9 Million In Q1 Fiscal 2010 17
May 18, 2009: Abiomed Provides Financial Guidance For Fiscal 2010 18
May 12, 2009: Abiomed Posts Net Loss Of $31.6 Million In Fiscal 2009 19
Feb 05, 2009: Abiomed Reports Q3 Fiscal 2009 Results 20
Jan 30, 2009: Abiomed To Report Q3 Fiscal 2009 Results 21
Nov 10, 2008: Abiomed Reports 2Q Fiscal 2009 Results 21
Oct 02, 2008: Abiomed Confirms Revenue Outlook For Fiscal Year 2009 22
Aug 07, 2008: Abiomed Reports 1Q Fiscal 2009 Results 22
May 21, 2008: Abiomed Reports Q4 Fiscal 2008 Results 23
Feb 07, 2008: Abiomed Reports Q3 Fiscal 2008 Results 24
Nov 08, 2007: Abiomed Reports Q2 Fiscal 2008 Results 25
Aug 09, 2007: Abiomed Reports Q1 Fiscal 2008 Results 26
May 17, 2007: Abiomed Reports Q4 Fiscal 2007 Results 26
Apr 26, 2007: Abiomed Announces Partial Exercise Of Over-Allotment Option 27
Mar 27, 2007: Abiomed Closes Sale Of Common Stock In Public Offering 27
Feb 05, 2007: Abiomed Reports Q3 Fiscal 2007 Results 27
Feb 02, 2007: Abiomed Reports Q3 Fiscal 2006 Results 28
Nov 08, 2006: Abiomed Reports Q2 Fiscal 2007 Results 28
Aug 08, 2006: Abiomed Reports Q1 Fiscal 2007 Results 29
May 08, 2006: Abiomed Reports Q4 Fiscal 2006 Results 30
Corporate Communications 30
Mar 05, 2009: Abiomed Appoints Vice President And General Manager, Global Sales And Marketing 30
Dec 22, 2008: Abiomed Appoints Vice President, CFO 31
May 22, 2008: Abiomed Appoints New Board Member 32
May 31, 2007: Abiomed Appoints New Director 32
Jan 16, 2007: Abiomed Appoints New Board Member 32
Jan 09, 2006: Abiomed Appoints Lead Director Of Its Board 32
Dec 19, 2005: Abiomed Appoints New CFO 32
Product News 32
Jan 07, 2010: Abiomed's Impella Helps Increase Revenues Of The Company 32
Jan 04, 2010: Abiomed Completes Recall Of iPulse Circulatory Support System 33
Apr 22, 2009: Abiomed Announces US 510(K) Approval For Impella 5.0 33
Dec 18, 2006: Abiomed Announces Positive Reimbursement Recommendation at Medicare Evidence Development & Coverage Advisory Committee Meeting 33
Jul 23, 2006: Abiomed Expands Availability Of Impella Circulatory Support Technologies With Regulatory Approvals In India 33
Jul 11, 2006: Abiomed's New Integrated Off-Pump Cannula Gets Clearance From FDA 34
Jun 27, 2006: FDA Approves ABIOMED'S IDE For IMPELLA 5.0 Minimally Invasive Cardiac Support Systems 34
Product Approvals 34
Apr 22, 2009: Abiomed Announces US 510(K) Approval For Impella 5.0 34
Jul 23, 2006: Abiomed Expands Availability Of Impella Circulatory Support Technologies With Regulatory Approvals In India 35
Jul 11, 2006: Abiomed's New Integrated Off-Pump Cannula Gets Clearance From FDA 35
Jun 27, 2006: FDA Approves ABIOMED'S IDE For IMPELLA 5.0 Minimally Invasive Cardiac Support Systems 35
Other Significant Developments 36
Jan 27, 2010: Abiomed Signs Partnership Agreement With Opsens To Utilize Sensor Technology For Impella 36
Mar 26, 2009: Abiomed To Showcase Impella Heart Recovery Platform At American College Of Cardiology Annual 2009 Meeting 36
Jan 21, 2009: Abiomed To Showcase Impella Heart Recovery Platform At STS 2009 36
Oct 13, 2008: Abiomed Reports Shipments Results For 2Q Fiscal 2009 37
Sep 02, 2008: Abiomed To Present At Morgan Stanley Global Healthcare Unplugged Conference 37
Jan 24, 2008: Abiomed To Host Symposium On Spectrum of Heart Recovery Technologies At STS 2008 37
Appendix 39
Methodology 39
About Global Markets Direct 39
Contact Us 39
Disclaimer 39
[Inhaltsverzeichnis ausblenden]

List of Tables
ABIOMED, Inc., Medical Equipment, Key Facts, 2009 1
ABIOMED Enters Into An Agreement With Opsens 9
ABIOMED Completes Public Offering Of $42.06 Million 10
ABIOMED Completes Public Offering Of $69.85 Million 11
ABIOMED Acquires Impella Cardiosystems 12

List of Figures
ABIOMED, Inc., Medical Equipment, Deals By Year, 2004 to YTD 2010 4
ABIOMED, Inc., Medical Equipment, Deals by Type, 2004 to YTD 2010 5
ABIOMED, Inc., Medical Equipment, Deals By Region, 2004 to YTD 2010 6
ABIOMED, Inc., Medical Equipment, Deals by Market, 2004 to YTD 2010 7
[Tabellenverzeichnis ausblenden]